- Home
- ICE vs LUCD Comparison
ICE vs LUCD Comparison
Compare ICE & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICE
- LUCD
- Stock Information
- Founded
- ICE 2000
- LUCD 2018
- Country
- ICE United States
- LUCD United States
- Employees
- ICE N/A
- LUCD N/A
- Industry
- ICE Investment Bankers/Brokers/Service
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ICE Finance
- LUCD Health Care
- Exchange
- ICE Nasdaq
- LUCD Nasdaq
- Market Cap
- ICE N/A
- LUCD 135.6M
- IPO Year
- ICE 2005
- LUCD 2021
- Fundamental
- Price
- ICE $178.33
- LUCD $1.13
- Analyst Decision
- ICE Strong Buy
- LUCD Strong Buy
- Analyst Count
- ICE 15
- LUCD 4
- Target Price
- ICE $186.07
- LUCD $3.88
- AVG Volume (30 Days)
- ICE 2.7M
- LUCD 961.7K
- Earning Date
- ICE 05-01-2025
- LUCD 05-14-2025
- Dividend Yield
- ICE 1.07%
- LUCD N/A
- EPS Growth
- ICE 10.92
- LUCD N/A
- EPS
- ICE 4.83
- LUCD N/A
- Revenue
- ICE $9,462,000,000.00
- LUCD $4,346,000.00
- Revenue This Year
- ICE $7.06
- LUCD $107.75
- Revenue Next Year
- ICE $6.09
- LUCD $231.37
- P/E Ratio
- ICE $36.96
- LUCD N/A
- Revenue Growth
- ICE 12.88
- LUCD 79.00
- 52 Week Low
- ICE $131.79
- LUCD $0.63
- 52 Week High
- ICE $178.80
- LUCD $1.80
- Technical
- Relative Strength Index (RSI)
- ICE 72.45
- LUCD 36.90
- Support Level
- ICE $162.94
- LUCD $1.19
- Resistance Level
- ICE $160.81
- LUCD $1.24
- Average True Range (ATR)
- ICE 3.50
- LUCD 0.07
- MACD
- ICE 1.86
- LUCD -0.01
- Stochastic Oscillator
- ICE 95.18
- LUCD 4.17
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.